Study: Metformin helps pancreatic cancer patients with diabetes

04/5/2012 | DailyRx.com

A study in Clinical Cancer Research revealed that pancreatic cancer patients with diabetes who took metformin lived longer than those who did not take the drug. Researchers looked at 302 patients with both conditions and found that 30.1% of metformin-treated patients survived after two years, compared with 15.4% of those who did not receive metformin.

View Full Article in:

DailyRx.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director Medical Affairs
Edwards Lifesciences
Irvine, CA
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Medical Director - Physician
Willamette Valley Community Health
Salem, OR
Area Reimbursement Manager (CT, MA, MD, ME, NH, NJ, NY, PA, VT)
SI-BONE, INC
Multiple Locations, SL_Multiple Locations
Medical Director - Physician
Willamette Valley Community Health
Salem, OR